DGAP-News: RHÖN-KLINIKUM AG / Key word(s): PreliminaryResults/Preliminary Results13.03.2014 / 07:00
Number of treated patients rises by 4 percent to approx. 2.65 millionFinancial figures for 2013 significantly affected by special influencesRevenues rise by approx. 5 percent to EURO 3.01 billionEBITDA falls by just under 6 percent to EURO 275 millionNet consolidated profit falls by just under 3 percent to EURO 90 millionOutlook for 2015 confirmed with an EBITDA margin of about 14 percentThe transaction sale of a total of 40 hospitals to Fresenius / Helios whichwas commenced during the last financial year and is now largely completeddid not affect the number of patients treated by RHÖN-KLINIKUM AG. Overallover 2.65 million people were treated in the 54 hospitals which stillbelonged to the corporate group in 2013; that is roughly 4 percent morethan during the previous year. Consequently the company's revenue also grewby approx. 5 percent to approx. EURO 3.01 billion and thus crossed the 3billion mark for the first time.However, particularly at the end of the year the transaction requiredconsiderable management resources both at the group headquarters and alsoin the individual hospitals. Earnings before interest, taxes, depreciationand amortisation (EBITDA) thus fell by approx. 6 percent to EURO275 million despite the increased revenues. Numerous special influences,such as costs for the necessary staff modifications in the groupadministration, considerable consultation expenses in connection with thesale transaction and other structural one-time effects - totalling betweenEURO 30 million and EURO 40 million at EBITDA level - came to bear here.Against this background the net consolidated profit also decreased slightlyby just under 3 percent to EURO 90 million."The achieved earnings are generally satisfactory in consideration of thechallenging framework conditions of handling the sale transaction," Dr. Dr.Martin Siebert, CEO of RHÖN KLINIKUM AG, explained. In 2013 outstandingwork for the overall benefit of patients was again carried out due to thededication of employees despite the uncertainty and extra load associatedwith the transaction. "We are now reaping the reward of our work followingthe successful sale. We let the shareholders have an appropriate share inthe sales proceeds and also have a more than solid financial basis for thechallenges of the future. With the new corporate structure we will place anemphasis on increasing efficiency and profitability without cutting back onthe quality of treatment," Jens-Peter Neumann, CFO of RHÖN-KLINIKUM AG,said.OutlookRHÖN-KLINIKUM AG will refrain from giving a target for revenues andearnings for the current financial year 2014. The prime reasons for thisare the unfinished structural changes in the company and the specialeffects which are caused by the sale and included in the balance sheet andwhich still have to be dealt with.The company expects revenues of EURO 1.06 billion to EURO 1.12 billion andearnings before interest, tax, depreciation and amortisation (EBITDA) ofbetween EURO 145 million and EURO155 million for 2015, the first full financial year with the new corporatestructure. Our outlook is subject to any regulatory changes which mayaffect reimbursement rates in the coming year."A new era has now begun for RHÖN-KLINIKUM AG. With ten hospitals in fivelocations and approx. 15,000 employees we shall now concentrate onexpanding our expertise in medical science and remain one of the largesthospital operators in Germany. With this focussed direction and streamlinedportfolio we can now concentrate all our strength again on offering ourpatients first-class yet affordable medical services. This will also have apositive effect on the level of earnings in the foreseeable future," Dr.Dr. Martin Siebert concluded.Summary of Key Ratios* 2013 2012 Change in %Patients treated 2,654,249 2,555,822 +3.9 %Revenues in million EURO 3,014 2,865 +5.2 %EBITDA in million EURO 275 292 -5.7 %Net consolidated profit 90 92 -2.6 %in million EURO* Provisional, uncertified financial figures with possible rounding-offdifferences **************************************************************************RHÖN-KLINIKUM AG is one of the largest healthcare providers in Germany.With ten hospitals in five locations and a total of 5,300 beds the companyintends to expand its expertise in medical science. The hospitals inBoizenburg, Cuxhaven and Waltershausen-Friedrichroda also currently belongto the corporate group. A total of approx. 15,000 employees work forRHÖN-KLINIKUM AG.Further information is available at: www.rhoen-klinikum-ag.com.Your Contact Persons:RHÖN-KLINIKUM AGAchim StruchholzGroup Division Head of Corporate CommunicationSchlossplatz 197616 Bad Neustadt / SaaleTelephone: + 49 - 9771 65-1327Facsimile: + 49 - 9771 65-1820E-Mail: kommunikation@rhoen-klinikum-ag.com Dr. Kai G. KlingerHead of Investor RelationsSchlossplatz 197616 Bad Neustadt / SaaleTelephone: + 49 - 9771 65-1318Facsimile: + 49 - 9771 99-1736E-Mail: kai.klinger@rhoen-klinikum-ag.com End of Corporate News
13.03.2014 Dissemination of a Corporate News, transmitted by DGAP - acompany of EQS Group AG.The issuer is solely responsible for the content of this announcement.DGAP's Distribution Services include Regulatory Announcements,Financial/Corporate News and Press Releases.Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Phone: +49 (0)9771 - 65-0 Fax: +49 (0)9771 - 97 467 E-mail: rka@rhoen-klinikum-ag.com Internet: www.rhoen-klinikum-ag.com ISIN: DE0007042301 WKN: 704230 Indices: MDAX Listed: Regulierter Markt in Frankfurt (Prime Standard), München; Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart End of News DGAP News-Service 
 257271 13.03.2014